Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2007-08-07
2007-08-07
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C540S542000
Reexamination Certificate
active
10820216
ABSTRACT:
Compounds of formula (I) or pharmaceutically acceptable salts thereof are providedwhere at least one of R2or R3is not hydrogen. The compounds of the present invention are N-methyl-D-aspartate (NMDA) receptor antagonists and are useful in treating a variety of conditions present in a mammal that benefit from inhibiting the NMDA receptor.
REFERENCES:
patent: 5124319 (1992-06-01), Baudy et al.
patent: 5168103 (1992-12-01), Kinney et al.
patent: 5240946 (1993-08-01), Kinney et al.
patent: 5624898 (1997-04-01), Frey, II
patent: 5990307 (1999-11-01), Asselin et al.
patent: 6011168 (2000-01-01), Asselin et al.
patent: 6451848 (2002-09-01), Behl et al.
patent: 2003/0114444 (2003-06-01), Brandt et al.
patent: 2004/0082543 (2004-04-01), Cheung
patent: 2005/0004074 (2005-01-01), Benjamin et al.
patent: 2005/0142192 (2005-06-01), Benjamin et al.
patent: 0 496 561 (1992-07-01), None
patent: 0 778 023 (1997-06-01), None
patent: 0 994 107 (2000-04-01), None
patent: WO 98/15542 (1998-04-01), None
patent: WO 99/06417 (1999-02-01), None
patent: WO 99/64041 (1999-12-01), None
patent: WO 03/031416 (2003-04-01), None
patent: WO 2004/039371 (2004-05-01), None
Brown et al., N-Methyl-D-Aspartate Receptor (NMDA) Antagonists as Potential Pain Therapeutics, Current Topics in Medicinal Chemistry, vol. 6, No. 8, pp. 749-770, 2006.
Lipton, Failures and Successess of NMDA Receptor Antagonists: Molecular Basis for the Use of Open-Channel Blockers like Memantine in the Treatment of Acute and Chronic Neurologic Insults, The Journal of the American Society for Experimental NeuroTherapeutics, vol. 1, No. 1, pp. 101-110, 2004.
Karlsten et al., Drug & Aging, 11(5), 398-412 (1997).
Hao et al., Pain, 66, 279-285 (1996).
Chaplan et al., Pharmacology & Experimental Therapeutics, 280(2), 829-838 (1997).
Suzuki et al., Pain, 91, 101-109 (2001).
Bennett, Journal of Pain & Symptom Management, 19(1 Suppl.), S2-S6 (2000).
Sang, Journal of Pain & Symptom Management, 19(1 Suppl.) S21-S25 (2000).
Pal et al., Burns, 23(5), 404-412 (1997).
Rogawski et al., Trends in Pharmaceutical Sciences, 14, 325-331 (1993).
Nicholson et al., Behavioural Pharmacology, 9, 231-243 (1998).
Mori et al., Behavioural Brain Research, 119, 33-40 (2001).
Baron et al., Psychopharmacology, 118, 42-51 (1995).
France et al., Journal of Pharmacology & Experimental Therapeutics, 257(2), 727-734 (1991).
France et al., European Journal of Pharmacology, 159, 133-139 (1989).
Olney et al., Science, 254, 1515-1518 (1991).
Fix et al., Experimental Neurology, 123, 204-215 (1998).
Bradford et al., Stroke & Cerebral Circulation, Abstract (1998).
Millan et al., Neuroscience Letters, 178, 139-143 (1994).
Kinney et al., J. Med. Chem., 41, 236-246 (1998).
McRoberts et al., Gastroenterology, 120(7), 1737-1748 (2001).
Olivar et al., Pain, 79, 67-73 (1999).
Rygh et al., Pain, 93, 15-21 (2001).
Tang et al., Nature, 401, 63-69 (1999).
Wei et al., Nature, 4(2), 164-169 (2001).
Chaplan, S.R., Journal of Neuroscience Methods, 53, 55-63 (1994).
Bennett, Gary et al., Pain, 33, 87-107 (1988).
Hewitt, David, The Clinical Journal of Pain, 16, S73-S79 (2000).
Woolf, et al., Pain, 44, 293-299 (1991).
Olney, et al., Science, 244, 1360-1362 (1989).
Abrahams et al., Emerging Drugs, 5(4), 385-413 (2000).
Herrling, P.L., Academic Press, Chapter 1, 1-6 (1997).
Baudy et al., J. Med. Chem. 36, 331-342 (1993).
Kristensen, et al., Database Biosis, Biosciences Information Service, Abstract XP002228851, 1992.
Baudy et al., J. Med. Chem. 44, 1516-1529 (2001).
Childers et al., Drugs of the Future, 27(7), 633-638 (2002).
Kristensen, et al., Pain, 51, 249-253 (1992).
Abou-Gharbia, Abstract Paper, Am. Chem. Sci., 221stMEDI 202 (2001).
B.M. Swahn et al., Bioorganic & Medicinal Chemistry Letters, 6(14), 1635-1640 (1996).
S.H. Wilen et al., Tetrahedron, 33, 2725-2736 (1977).
C.R. Behl et al., Advanced Drug Delivery Reviews, 29, 117-133 (1998).
A. Hussain, Advanced Drug Delivery Reviews, 29, 39-49 (1998).
T. Mosconi et al., Pain, 64, 37-57 (1996).
M. Brandt et al., The Journal of Pharmacology & Experimental Therapeutics, 296(3), 939-946 (2001).
H. Zia et al., Clinical Research & Regulatory Affairs, 10(2), 99-135 (1993).
G.D. Parr, Pharmacy International, 4, 202-205 (1983).
G.J. Bennett et al., Pain, 33, 87-107 (1988).
S.C. Sutton et al., Pharmaceutical Research, 10(6), 924-926 (1993).
S.R. Chaplan et al., Journal of Neuroscience Methods, 53, 55-63 (1994).
F. Menniti, et al., European Journal of Pharmacology, 331, 117-126 (1997).
B. Chizh et al., TRENDS in Pharmacological Sciences, 22(12), 636-642 (2001).
S. Boyce et al., Neuropharmacology, 38, 611-623 (1999).
V. Mutel et al., Journal of Neurochemistry, 70, 2147-2155 (1998).
Rogers, Kathryn, Wyeth-Perzinfotel (EAA-090) NMDA Antagonist for the Treatment of Diabetic Neuropathy, 47 pages, presented on Jun. 9, 2004 at the SMI Pain Conference, London, England.
Kinney W.A., et al., Journal of Medicinal Chemistry; 35(25), 4720-4726 (1992).
Hatse S., et al., Molecular Pharmacology, 50(5), 1231-1242 (1996).
Farquhar D, et al., Journal of Pharmaceutical Sciences, 72(3), 324-325 (1983).
Lombaert S DE, et al., Journal of Medicinal Chemistry, 37(4), 498-511 (1994).
Starrett J.E., et al., Journal of Medicinal Chemistry, 37(12), 1857-1864 (1994).
Farquhar D, et al., Journal of Medicinal Chemistry, 37(23), 3902-3909 (1994).
Lefebvre I, et al., Journal of Medicinal Chemistry, 38(20), 3941-3950 (1995).
Oliyai R, et al., Nucleosides, Nucleotides & Nucleic Acids, 20(4-7), 1295-1298 (2001).
Yuan L.C., et al., Pharmaceutical Research, 18(2), 234-237 (2001).
Frankova D, et al., Nucleosides & Nucleotides, 18(4/5), 955-958 (1999).
Eisenberg E J, et al., Nucleosides, Nucleotides & Nucleic Acids, 20(4-7), 1091-1098 (2001).
Robbins B L, et al., Antimicrobial Agents and Chemotherapy, 42(3), 612-617 (1998).
Naesens L., et al., Antimicrobial Agents and Chemotherapy, 42(7), 1568-1573 (1998).
Mulato A.S., et al., Antimicrobial Agents and Chemotherapy, 42(7), (1998). 1620-1628.
Kahn S.R., et al., Tetrahedron Letters, 40(4), 607-610 (1999).
Baudy Reinhardt B.
Butera John A.
Coleman Brenda
Woodcock & Washburn LLP
Wyeth
LandOfFree
Derivatives of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3869357